| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.004 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |